Progress in drug therapy for COVID-19 infection
The novel coronavirus pneumonia caused by COVID-19 has emerged in Wuhan at the end of Dec. 2019, and then has spread across our country. To date, no specific therapy against the new virus is available. The clinical efficacy of some antiviral drugs, such as remdesivir, chloroquine phosphate, abidor a...
| Published in: | Jichu yixue yu linchuang |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | Chinese |
| Published: |
Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College.
2020-10-01
|
| Subjects: | |
| Online Access: | http://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/a200424.pdf |
